Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Secretagogues treatment for human growth hormone deficiency in adults:

Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels. Sigalos JT et al. Am J Mens Health. (2017)

The macimorelin-stimulated growth hormone test for adult growth hormone deficiency diagnosis. Agrawal V et al. Expert Rev Mol Diagn. (2014)

Growth hormone deficiency in children. Richmond EJ et al. Pituitary. (2008)

Search results

Items: 1 to 20 of 26

1.

Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels.

Sigalos JT, Pastuszak AW, Allison A, Ohlander SJ, Herati A, Lindgren MC, Lipshultz LI.

Am J Mens Health. 2017 Nov;11(6):1752-1757. doi: 10.1177/1557988317718662. Epub 2017 Aug 22.

2.

Growth hormone secretagogues: out of competition.

Pinyot A, Nikolovski Z, Bosch J, Such-Sanmartín G, Kageyama S, Segura J, Gutiérrez-Gallego R.

Anal Bioanal Chem. 2012 Jan;402(3):1101-8. doi: 10.1007/s00216-011-5544-8. Epub 2011 Nov 15.

PMID:
22083629
3.

Somatopause: state of the art.

Di Somma C, Brunelli V, Savanelli MC, Scarano E, Savastano S, Lombardi G, Colao A.

Minerva Endocrinol. 2011 Sep;36(3):243-55. Review.

PMID:
22019753
4.

GH use in the transition of adolescence to adulthood.

Mauras N.

Endocr Dev. 2010;18:109-25. doi: 10.1159/000316131. Epub 2010 Jun 3. Review.

PMID:
20523021
5.

Impact of growth hormone (GH) deficiency and GH replacement upon thymus function in adult patients.

Morrhaye G, Kermani H, Legros JJ, Baron F, Beguin Y, Moutschen M, Cheynier R, Martens HJ, Geenen V.

PLoS One. 2009 May 22;4(5):e5668. doi: 10.1371/journal.pone.0005668.

6.

[News options and preparations in growth hormone therapy].

Aguiar-Oliveira MH, Meneguz-Moreno RA, Nascimento-Junior AC.

Arq Bras Endocrinol Metabol. 2008 Jul;52(5):917-24. Portuguese.

7.

GHRH and GH secretagogues: clinical perspectives and safety.

Aimaretti G, Baldelli R, Corneli G, Bellone S, Rovere S, Croce C, Ragazzoni F, Giordano R, Arvat E, Bona G, Ghigo E.

Pediatr Endocrinol Rev. 2004 Nov;2 Suppl 1:86-92. Review.

PMID:
16456487
8.

Associated hormonal decline in aging: is there a role for GH therapy in aging men?

Lombardi G, Di Somma C, Rota F, Colao A.

J Endocrinol Invest. 2005;28(3 Suppl):99-108. Review.

PMID:
16042367
9.

Influence of growth hormone on cardiovascular health and disease.

Colao A, Di Somma C, Vitale G, Filippella M, Lombardi G.

Treat Endocrinol. 2003;2(5):347-56. Review.

PMID:
15981951
10.

Ageing, growth hormone and physical performance.

Lanfranco F, Gianotti L, Giordano R, Pellegrino M, Maccario M, Arvat E.

J Endocrinol Invest. 2003 Sep;26(9):861-72. Review.

PMID:
14964439
11.

Growth hormone-releasing hormone and growth hormone secretagogues in normal aging.

Merriam GR, Schwartz RS, Vitiello MV.

Endocrine. 2003 Oct;22(1):41-8. Review.

PMID:
14610297
12.

Oral administration of the growth hormone secretagogue NN703 in adult patients with growth hormone deficiency.

Svensson J, Monson JP, Vetter T, Hansen TK, Savine R, Kann P, Bex M, Reincke M, Hagen C, Beckers A, Ilondo MM, Zdravkovic M, Bengtsson BA, Korbonits M; NN703 Clinical Research Group.

Clin Endocrinol (Oxf). 2003 May;58(5):572-80.

13.

Clinical pharmacology of human growth hormone and its secretagogues.

Root AW, Root MJ.

Curr Drug Targets Immune Endocr Metabol Disord. 2002 Apr;2(1):27-52. Review.

PMID:
12477295
14.

GH-related and extra-endocrine actions of GH secretagogues in aging.

Muller EE, Rigamonti AE, Colonna Vde G, Locatelli V, Berti F, Cella SG.

Neurobiol Aging. 2002 Sep-Oct;23(5):907-19. Review.

PMID:
12392795
15.

Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery.

Broglio F, Guarracino F, Benso A, Gottero C, Prodam F, Granata R, Avogadri E, Muccioli G, Deghenghi R, Ghigo E.

Eur J Pharmacol. 2002 Jul 19;448(2-3):193-200.

PMID:
12144941
16.

The impact of cranial irradiation on GH responsiveness to GHRH plus GH-releasing peptide-6.

Popovic V, Pekic S, Golubicic I, Doknic M, Dieguez C, Casanueva FF.

J Clin Endocrinol Metab. 2002 May;87(5):2095-9.

PMID:
11994347
17.

Growth hormone deficiency in the transition adolescent: should treatment be continued in adult life?

Aimaretti G, Corneli G, Bellone S, Baffoni C, Camanni F, Ghigo E.

J Pediatr Endocrinol Metab. 2001;14 Suppl 5:1233-42; discussion 1261-2. Review.

PMID:
11964018
18.

Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.

van den Berghe G, Weekers F, Baxter RC, Wouters P, Iranmanesh A, Bouillon R, Veldhuis JD.

J Clin Endocrinol Metab. 2001 Jul;86(7):3217-26.

PMID:
11443192
19.

New paradigms for growth hormone therapy in children.

Wetterau L, Cohen P.

Horm Res. 2000;53 Suppl 3:31-6. Review.

PMID:
10971101
20.

Age-related changes in growth hormone secretion: should the somatopause be treated?

Cummings DE, Merriam GR.

Semin Reprod Endocrinol. 1999;17(4):311-25. Review.

PMID:
10851571

Supplemental Content

Loading ...
Support Center